| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/14/2004 | WO2004087751A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 10/14/2004 | WO2004087750A2 A method for oxygen regulated production of recombinant staphylokinase |
| 10/14/2004 | WO2004087749A2 Nontypeable haemophilus influenzae virulence factors |
| 10/14/2004 | WO2004087748A1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
| 10/14/2004 | WO2004087747A2 Citrullinated synthetic peptides and uses thereof |
| 10/14/2004 | WO2004087746A2 Staphylococcus epidermidis antigens |
| 10/14/2004 | WO2004087745A1 Analytical method and kit thereof |
| 10/14/2004 | WO2004087739A1 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 10/14/2004 | WO2004087738A2 Lupus antibodies for passive immunotherapy of hiv/aids |
| 10/14/2004 | WO2004087730A2 Method for producing diverse libraries of encoded polymers |
| 10/14/2004 | WO2004087622A2 Gpr54 receptor agonist and antagonist useful for the treatmentt of gonadotropin related diseases |
| 10/14/2004 | WO2004087217A1 An animal model of schizophrenia |
| 10/14/2004 | WO2004087206A2 Methods of treating diabetes by blocking vegf-mediated activity |
| 10/14/2004 | WO2004087201A2 Mva virus expressing modified hiv envelope, gag, and pol genes |
| 10/14/2004 | WO2004087196A2 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087125A1 Amino acid derivatives as inhibitors of mammalian sodium channels |
| 10/14/2004 | WO2004087063A2 Use of erythropoietin in stroke recovery |
| 10/14/2004 | WO2004087062A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 10/14/2004 | WO2004087058A2 Targeted mhc class i alpha3 vaccine delivery systems |
| 10/14/2004 | WO2004087057A2 Methods for inhibition of angiogenesis |
| 10/14/2004 | WO2004087054A2 Methods for modulating gastric secretion using prokineticin receptor antagonists. |
| 10/14/2004 | WO2004086853A2 Generation of plants with improved pathogen resistance |
| 10/14/2004 | WO2004074245A3 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 10/14/2004 | WO2004072253A9 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 10/14/2004 | WO2004072093A3 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 10/14/2004 | WO2004063225A3 Novel fibulin-like polypeptides |
| 10/14/2004 | WO2004060269A3 Mda-7 and free radicals in the treatment of cancer |
| 10/14/2004 | WO2004058816A3 Inclusion bodies for the oral vaccination of animals |
| 10/14/2004 | WO2004056870A3 Method for separation of antithrombin |
| 10/14/2004 | WO2004052914A8 Compositions and methods for inhibiting malaria protease falcipain-2 |
| 10/14/2004 | WO2004048567A3 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 10/14/2004 | WO2004048527A8 Cells resistant to chemotherapeutic compounds and uses thereof |
| 10/14/2004 | WO2004047623A3 Methods for identifying risk of breast cancer and treatments thereof |
| 10/14/2004 | WO2004046182A3 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 10/14/2004 | WO2004043988A3 Ptprk immunogenic peptide |
| 10/14/2004 | WO2004043376A3 Compositions and methods for treating or preventing pneumococcal infection |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004041152A3 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 10/14/2004 | WO2004032831A3 Metalization of microtubules |
| 10/14/2004 | WO2004031233A3 Novel chemokine-like polypeptides |
| 10/14/2004 | WO2004031207A3 Candida albicans cofilin |
| 10/14/2004 | WO2004029621A3 Tcell mediator/modulator assay based upon tcell restricted transgenic mouse |
| 10/14/2004 | WO2004029085A3 METHOD FOR THE RATIONAL MUTAGENESIS OF A/ss T CELL RECEPTORS AND CORRESPONDINGLY MUTATED MDM2 PROTEIN-SPECIFIC A/ss T-CELL RECEPTORS |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004015130A3 Modulators of rabggt and methods of use thereof |
| 10/14/2004 | WO2004015067A3 Sperm-specific cation channel, catsper-3, and uses therefor |
| 10/14/2004 | WO2004013301A3 Seed-associated promoter sequences |
| 10/14/2004 | WO2004009780A3 Preventing ischemia-induced cell damage |
| 10/14/2004 | WO2004009632A3 Method for the production of an immunostimulating mucin (muc1) |
| 10/14/2004 | WO2004007679A3 Dendritic cell pontentiation |
| 10/14/2004 | WO2003104811A3 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases |
| 10/14/2004 | WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2003087135A3 Novel pheromone receptor |
| 10/14/2004 | WO2003076642A3 Novel proteins and nucleic acids encoding same |
| 10/14/2004 | WO2003076597A3 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | WO2003072700A3 Androgen receptor overexpressing skeletal myoblasts |
| 10/14/2004 | WO2003065985A3 Uses of mammalian cytokine; related reagents |
| 10/14/2004 | WO2003064592A3 Inhibitors of autoinducer transporters |
| 10/14/2004 | WO2003060099A8 Methods and apparatus for spinning spider silk protein |
| 10/14/2004 | WO2002064732A8 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF |
| 10/14/2004 | WO2002055664A3 Modulating insulin receptor signaling |
| 10/14/2004 | WO2002030980A8 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 10/14/2004 | WO2001094377A3 Metalloprotease peptide substrates and methods |
| 10/14/2004 | WO2001075067A8 Novel nucleic acids and polypeptides |
| 10/14/2004 | US20040205846 Comprises solanum americanum proteinase inhibitor for use tool for inhibiting programmed cell death in plants; delayed senescence; insect resistant plants; biological pest control |
| 10/14/2004 | US20040205844 Preparation of heterologous proteins on oil bodies |
| 10/14/2004 | US20040205843 Geminivirus resistant transgenic plants |
| 10/14/2004 | US20040205839 Comprises nucleotide sequences coding polypeptide associated with mismatch repair for use in identifying modulators which enhance mutational rate in plants; directed evolution |
| 10/14/2004 | US20040205837 Transgenic mouse over-expressing calreticulin (CRT) in vascular smooth muscle cells |
| 10/14/2004 | US20040205836 Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss |
| 10/14/2004 | US20040205834 System for inducible expression in eukaryotic cells |
| 10/14/2004 | US20040205832 Transgenically produced decorin |
| 10/14/2004 | US20040204862 Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/14/2004 | US20040204581 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 10/14/2004 | US20040204580 Membrane protein for use in identifying modulators for treatment of thermogenesis, obesity, cachexia, and metabolic disorders |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204575 Bovine lymphocyte-derived antibacterial protein |
| 10/14/2004 | US20040204574 TSA305 gene |
| 10/14/2004 | US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders |
| 10/14/2004 | US20040204566 Chemically-modified G-CSF |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204564 CRFR1 selective ligands |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040204562 Polynucleotides encoding cytokine receptor zalpha11 |
| 10/14/2004 | US20040204490 Contacting with neurotransmitter recognition site ligand in the presence and absence of a steroid-based molecule; chimeric isoform; use in therapy of neurological disorders including ischemic stroke, epilepsy and schizophrenia |
| 10/14/2004 | US20040204388 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein |
| 10/14/2004 | US20040204376 Focal calcium channel modulation |
| 10/14/2004 | US20040204365 Methods of using cyanovirins to inhibit viral infection |
| 10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
| 10/14/2004 | US20040204363 providing a complex containing peptide or protein of interest covalently linked to amino terminal ATP binding domain of a heat shock protein 70 (hsp70) or the carboxyl terminal peptide binding domain of an hsp70, contacting the cell with the complex for entry of the complex into the cell |
| 10/14/2004 | US20040204362 Alpha-conotoxin peptides |
| 10/14/2004 | US20040204361 Kdel receptor inhibitors |
| 10/14/2004 | US20040204360 a nucleotide sequence encoding a protein of the ONECUT family characterized by the presence of a single CUT domain and the presence of an F48M50 dyad in the homeo domain for the treatment or for the prevention of diabetes or cancer, in particular to a genetic/cellular therapy |
| 10/14/2004 | US20040204358 Reducing culling in herd animals growth hormone releasing hormone (GHRH) |
| 10/14/2004 | US20040204353 Amino acid sequences which bind calcitonin receptor-like proteins for use in identifying modulators which treat cardiovascular, reproductive, gastrointestinal and hypotension; mimetics |
| 10/14/2004 | US20040204352 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease |